InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by FLESHER GREGORY J., Chairman & CEO. Officer active across 1 companies, notably Reneo Pharmaceuticals, Inc.. Cumulatively, 4 disclosures have been recorded. Total volume traded: €109k. The latest transaction was disclosed on 10 December 2021 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations4 total
0100,000 shares0
Common Stock
SEC:0001209191-21-069443·
0100,000 shares0
Common Stock
SEC:0001209191-21-069443:0·
€54,3558,000 shares@ €6.7944100.0% of flow
Common Stock
SEC:0001209191-21-053522·
Ideal exit: 22 May 2022 (T+270)
€54,3558,000 shares@ €6.794450.0% of flow
Common Stock
SEC:0001209191-21-053522:0·
Ideal exit: 22 May 2022 (T+270)
4 of 4 declarations
About FLESHER GREGORY J.
Flesher Gregory J. is the President and CEO of Reneo Pharmaceuticals, Inc. He leads the company with a focus on developing innovative treatments for metabolic diseases. His leadership and strategic vision are essential in guiding Reneo's research and development efforts aimed at improving patients' quality of life.
